
Read More
Pharma Stock Emcure Pharmaceuticals Jumps 6% to Fresh 52-Week High; Board M...
Board to Consider Audited Q4FY26 Results and Final Dividend on 5 May; Public Shareholding Rises to 1...

Board to Consider Audited Q4FY26 Results and Final Dividend on 5 May; Public Shareholding Rises to 1...

Emcure Pharmaceuticals cuts prices of its semaglutide injection Poviztra®, making weight management ...

The stock price has surged over 53.21 per cent in the last 1 year and delivered approximately 68.41 ...

The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-wee...

The stock is up by 20 per cent from its 52-week low of Rs 911.75 per share....

The company’s shares have delivered an impressive return of around 30 per cent to its shareholders....

In this analysis, we take a closer look at Emcure Pharmaceuticals Ltd and present you with the exclu...